Article

A Randomized Trial of Dialectical Behavior Therapy Versus General Psychiatric Management for Borderline Personality Disorder

Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
American Journal of Psychiatry (Impact Factor: 13.56). 09/2009; 166(12):1365-74. DOI: 10.1176/appi.ajp.2009.09010039
Source: PubMed

ABSTRACT The authors sought to evaluate the clinical efficacy of dialectical behavior therapy compared with general psychiatric management, including a combination of psychodynamically informed therapy and symptom-targeted medication management derived from specific recommendations in APA guidelines for borderline personality disorder.
This was a single-blind trial in which 180 patients diagnosed with borderline personality disorder who had at least two suicidal or nonsuicidal self-injurious episodes in the past 5 years were randomly assigned to receive 1 year of dialectical behavior therapy or general psychiatric management. The primary outcome measures, assessed at baseline and every 4 months over the treatment period, were frequency and severity of suicidal and nonsuicidal self-harm episodes.
Both groups showed improvement on the majority of clinical outcome measures after 1 year of treatment, including significant reductions in the frequency and severity of suicidal and nonsuicidal self-injurious episodes and significant improvements in most secondary clinical outcomes. Both groups had a reduction in general health care utilization, including emergency visits and psychiatric hospital days, as well as significant improvements in borderline personality disorder symptoms, symptom distress, depression, anger, and interpersonal functioning. No significant differences across any outcomes were found between groups.
These results suggest that individuals with borderline personality disorder benefited equally from dialectical behavior therapy and a well-specified treatment delivered by psychiatrists with expertise in the treatment of borderline personality disorder.

Download full-text

Full-text

Available from: David L Streiner, Aug 10, 2015
0 Followers
 · 
191 Views
  • Source
    • "The strict exclusion criteria that often characterize RCTs have produced client samples that in many cases are not representative of the populations seen in routine settings (Westen, Novotny, & Thompson- Brenner, 2004), and many clinicians have expressed concerns that the findings from efficacy trials are not clinically relevant and do not transfer easily to routine practice. Awareness of this problem has prompted a rise in the number of CBT trials that include participants who are more typical of those in routine practice, such as individuals with significant comorbidities and/or who are receiving concurrent medication (e.g., DeRubeis et al., 2005; McMain et al., 2009). Confidence in a treatment is stronger if the effects observed in RCTs are replicated in effectiveness trials. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cognitive behaviour therapy (CBT), an umbrella term that includes a diverse group of treatments, is defined by a strong commitment to empiricism. While CBT has a robust empirical base, areas for improvement remain. This article reviews the status of the current empirical base and its limitations, and presents future directions for advancement of the field. Ultimately, studies are needed that will identify the predictors, mediators, and moderators of treatment response in order to increase knowledge on how to personalize interventions for each client and to strengthen the impact of CBT. Efforts to advance the dissemination and implementation of CBT, innovative approaches such as practice-oriented research, and the advantages of incorporating new and existing technologies, are discussed as well.
    Psychotherapy Research 02/2015; 25(3). DOI:10.1080/10503307.2014.1002440 · 1.75 Impact Factor
  • Source
    • "specified strategies, forming a complex array of treatment elements (e.g. each consultation team designates a team leader). To date, there have been at least 11 randomized controlled trials of DBT (Bohus et al. 2004; Carter et al. 2010; Koons et al. 2001; Linehan et al. 1991, 1999, 2002, 2006; McMain et al. 2009; Safer et al. 2001; Telch et al. 2001; Verheul et al. 2003). DBT increases treatment retention while reducing symptoms of BPD, non-suicidal self-injury, substance abuse, binging and purging, depression , and anger (Lynch et al. 2007), earning recommendations from the Substance "
    [Show abstract] [Hide abstract]
    ABSTRACT: Guided by the Consolidated Framework for Implementation Research, this mixed method study explored the relationship between inner setting variables and dialectical behavior therapy (DBT) implementation. Intensively trained DBT clinicians completed an online quantitative survey (n = 79) and a subset were sequentially interviewed using qualitative methods (n = 20) to identify relationships between inner setting variables and DBT implementation. Four interpersonal variables-team cohesion, team communication, team climate, and supervision-were correlated with the quantity of DBT elements implemented. Qualitative themes corroborated these findings. Additional variables were connected to implementation by either quantitative or qualitative findings, but not both.
    Administration and Policy in Mental Health and Mental Health Services Research 10/2014; DOI:10.1007/s10488-014-0602-0 · 3.44 Impact Factor
  • Source
    • "In terms of directions for future research, none of the five comprehensive treatments of BPD emphasize shame (Linehan, Armstrong, Suarez, Allmon, & Heard, 1991; Bateman & Fonagy, 1999; Giesen-Bloo et al., 2006; Clarkin, Levy, Lenzenweger, & Kernberg, 2007; McMain et al., 2009). And clinicians in the community tend to focus on rage and affective volatility in their treatment of the affective symptoms of patients with BPD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The current study had two aims. The first was to examine the course of shame over 16 years of prospective follow-up among borderline patients and axis II comparison subjects. The second was to determine risk factors associated with feelings of shame among borderline patients. A total of 290 borderline inpatients and 72 axis II comparison subjects were assessed using a series of semi-structured interviews and self-report measures at baseline, and 87% of surviving patients were reassessed at eight waves of follow-up. Borderline patients reported significantly higher levels (2.6 times) of shame (assessed with one item) across 16 years of follow-up than axis II comparison subjects. However, the severity of shame decreased (78% relative decline) significantly over time for both groups. Regarding risk factors, four lifetime adversity risk factors were found to be significantly associated with feelings of shame. Two of these factors (severity of childhood sexual abuse and severity of childhood neglect) remained significant in multivariate analyses. Taken together, the results of this study suggest that borderline patients struggle with intense but decreasing feelings of shame. They also suggest that childhood adversities are significant risk factors for this dysphoric affective state. Copyright © 2014 John Wiley & Sons, Ltd.
    Personality and Mental Health 08/2014; 8(3). DOI:10.1002/pmh.1258 · 1.10 Impact Factor
Show more